Cargando…
GSK3 is a metabolic checkpoint regulator in B cells
B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that g...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310963/ https://www.ncbi.nlm.nih.gov/pubmed/28114292 http://dx.doi.org/10.1038/ni.3664 |
_version_ | 1782507948230049792 |
---|---|
author | Jellusova, Julia Cato, Matthew H. Apgar, John R. Ramezani-Rad, Parham Leung, Charlotte Chen, Cindi Richardson, Adam D. Conner, Elaine M. Benschop, Robert J. Woodgett, James R. Rickert, Robert C. |
author_facet | Jellusova, Julia Cato, Matthew H. Apgar, John R. Ramezani-Rad, Parham Leung, Charlotte Chen, Cindi Richardson, Adam D. Conner, Elaine M. Benschop, Robert J. Woodgett, James R. Rickert, Robert C. |
author_sort | Jellusova, Julia |
collection | PubMed |
description | B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (GSK3) is a metabolic sensor that promotes the survival of naïve recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, GSK3 was selectively required for CD40-mediated regulation of B cell size, mitochondria biogenesis, glycolysis and reactive oxygen species (ROS) production. GSK3 was required to prevent metabolic collapse and ROS-induced apoptosis when glucose became limiting, functioning in part by repressing c-Myc-dependent growth. Importantly, we found that GSK3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment. |
format | Online Article Text |
id | pubmed-5310963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-53109632017-07-23 GSK3 is a metabolic checkpoint regulator in B cells Jellusova, Julia Cato, Matthew H. Apgar, John R. Ramezani-Rad, Parham Leung, Charlotte Chen, Cindi Richardson, Adam D. Conner, Elaine M. Benschop, Robert J. Woodgett, James R. Rickert, Robert C. Nat Immunol Article B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (GSK3) is a metabolic sensor that promotes the survival of naïve recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, GSK3 was selectively required for CD40-mediated regulation of B cell size, mitochondria biogenesis, glycolysis and reactive oxygen species (ROS) production. GSK3 was required to prevent metabolic collapse and ROS-induced apoptosis when glucose became limiting, functioning in part by repressing c-Myc-dependent growth. Importantly, we found that GSK3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment. 2017-01-23 2017-03 /pmc/articles/PMC5310963/ /pubmed/28114292 http://dx.doi.org/10.1038/ni.3664 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Jellusova, Julia Cato, Matthew H. Apgar, John R. Ramezani-Rad, Parham Leung, Charlotte Chen, Cindi Richardson, Adam D. Conner, Elaine M. Benschop, Robert J. Woodgett, James R. Rickert, Robert C. GSK3 is a metabolic checkpoint regulator in B cells |
title | GSK3 is a metabolic checkpoint regulator in B cells |
title_full | GSK3 is a metabolic checkpoint regulator in B cells |
title_fullStr | GSK3 is a metabolic checkpoint regulator in B cells |
title_full_unstemmed | GSK3 is a metabolic checkpoint regulator in B cells |
title_short | GSK3 is a metabolic checkpoint regulator in B cells |
title_sort | gsk3 is a metabolic checkpoint regulator in b cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310963/ https://www.ncbi.nlm.nih.gov/pubmed/28114292 http://dx.doi.org/10.1038/ni.3664 |
work_keys_str_mv | AT jellusovajulia gsk3isametaboliccheckpointregulatorinbcells AT catomatthewh gsk3isametaboliccheckpointregulatorinbcells AT apgarjohnr gsk3isametaboliccheckpointregulatorinbcells AT ramezaniradparham gsk3isametaboliccheckpointregulatorinbcells AT leungcharlotte gsk3isametaboliccheckpointregulatorinbcells AT chencindi gsk3isametaboliccheckpointregulatorinbcells AT richardsonadamd gsk3isametaboliccheckpointregulatorinbcells AT connerelainem gsk3isametaboliccheckpointregulatorinbcells AT benschoprobertj gsk3isametaboliccheckpointregulatorinbcells AT woodgettjamesr gsk3isametaboliccheckpointregulatorinbcells AT rickertrobertc gsk3isametaboliccheckpointregulatorinbcells |